Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2016 Apr 21:14:63.
doi: 10.1186/s12955-016-0465-z.

Impact of pulmonary exacerbations and lung function on generic health-related quality of life in patients with cystic fibrosis

Caitlyn T Solem  1 , Montserrat Vera-Llonch  2 , Sizhu Liu  3 , Marc Botteman  3 , Brenda Castiglione  2
Affiliations
Randomized Controlled Trial

Impact of pulmonary exacerbations and lung function on generic health-related quality of life in patients with cystic fibrosis

Caitlyn T Solem et al. Health Qual Life Outcomes. .

Abstract

Background: The analysis aimed to examine the impact of pulmonary exacerbations (PEs) and lung function on generic measures of HRQL in patients with cystic fibrosis (CF) using trial-based data.

Methods: In a 48-week randomized, placebo-controlled study of ivacaftor in patients ≥12 years with CF and a G551D-CFTR mutation the relationship between PEs, PE-related hospitalizations and percent predicted forced expiratory volume in one second (ppFEV1) with EQ-5D measures (index and visual analog scale [VAS]) was examined in post-hoc analyses. Multivariate mixed-effects models were employed to describe the association of PEs, PE-related hospitalizations, and ppFEV1 on EQ-5D measures.

Results: One hundred sixty one patients (age: mean 25.5 [SD 9.5] years; baseline ppFEV1: 63.6 [16.4]) contributed 1,214 observations (ppFEV1: no lung dysfunction [n = 157], mild [n = 419], moderate [n = 572], severe [n = 66]). Problems were most frequently reported on pain/discomfort, anxiety/depression, and usual activities EQ-5D items. The mean (SE) EQ-5D index nominally decreased (worsened) with worsening severity of lung dysfunction (P = 0.070): 0.931 (0.023); mild: 0.923 (0.021); moderate: 0.904 (0.018); severe: 0.870 (0.020). 146 PEs were experienced by 72 patients, including 52 PEs (35.6 %) that required hospitalization. Mean EQ-5D index and VAS scores were lowest (worst) within 1 week (before or after PE start) for PEs requiring hospitalization. Pulmonary exacerbations, PE-related hospitalizations, and ppFEV1 were significant predictors of EQ-5D index and VAS.

Conclusions: In a clinical study of patients with CF (≥12 years of age and a G551D-CFTR mutation), PEs, primarily those requiring hospitalization, were associated with low EQ-5D index and VAS scores. The impact of ppFEV1 was relatively smaller. Reducing PEs, in particular those requiring hospitalization, would likely improve HRQL among these patients.

Trial registration: ClinicalTrials.gov, NCT00909532 ; URL: clinicaltrials.gov, May 26, 2009.

Keywords: Cystic fibrosis; EQ-5D; Lung function; Pulmonary exacerbation.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Mean EQ-5D Index and VAS Scores by ppFEV1 (Unadjusted)
Fig. 2
Fig. 2
EQ-5D Index by Time since PE Start and Hospitalization
Fig. 3
Fig. 3
EQ-5D VAS Scores by Time since PE Start and Hospitalization
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Patrick DL, Deyo RA. Generic and disease-specific measures in assessing health status and quality of life. Med Care. 1989;27(3 Suppl):S217-32. Review. PubMed PMID: 2646490. - PubMed
    1. Sheppard MN, Nicholson AG. The pathology of cystic fibrosis. Curr Diagn Pathol. 2002;8(1):50–9.
    1. Boucher RC. Airway surface dehydration in cystic fibrosis: pathogenesis and therapy. (0066–4219 (Print)). - PubMed
    1. de Boer K, Vandemheen KL, Tullis E, Doucette S, Fergusson D, Freitag A, Paterson N, Jackson M, Lougheed MD, Kumar V, Aaron SD. Exacerbation frequency and clinical outcomes in adult patients with cystic fibrosis. Thorax. 2011;66(8):680-5. doi:10.1136/thx.2011.161117. Epub 2011 Jun 15. PubMed PMID: 21680566. - PubMed
    1. Habib AR, Manji J, Wilcox PG, Javer AR, Buxton JA, Quon BS. A systematic review of factors associated with health-related quality of life in adolescents and adults with cystic fibrosis. Ann Am Thorac Soc. 2015;12(3):420-8. doi:10.1513/AnnalsATS.201408-393OC. Review. PubMed PMID: 25642976. - PubMed

Publication types

Associated data